Dutch medical device maker Philips said Monday it had reached a $1.1 billion deal in the United States to settle lawsuits ...

The company says: "Philips and Philips Respironics do not admit any fault or liability, or that any injuries were caused by Respironics' devices." Profit and prosper with the best of expert advice ...

Koninklijke Philips tackles challenges in China while focusing on AI and cost-cutting. Find out why PHG stock is a buy with ...

The outlook includes the impact of the recently announced US-China tariffs. It excludes ongoing Philips Respironics-related legal proceedings, including the investigation by the US Department of ...

We took significant steps to address the consequences of the Respironics recall. We know there's more to do and are very focused on driving further improvements. More recently, Philips Respironics ...

The powerful Inspiration Elite is the newest and lightest compressor nebulizer system in the Respironics family is here. It's durable, easy to use and easy to maintain. But best of all ...

Koninklijke Philips NV (NYSE:PHG) reported strong profitability improvement and cash flow for Q4 and the full year 2024. The company achieved significant milestones in resolving the Respironics ...

We strengthened our fundamentals and resolved significant US litigation relating to the Respironics recall. Despite double-digit declines in demand in both consumer and health systems in China ...

The outlook includes the impact of the recently announced US-China tariffs. It excludes ongoing Philips Respironics-related legal proceedings, including the investigation by the US Department of ...